400 related articles for article (PubMed ID: 2312718)
21. Morphology of osteoclasts in resorbing fetal rat bone explants: effects of PTH and AIF in vitro.
Wezeman FH; Kuettner KE; Horton JE
Anat Rec; 1979 Jul; 194(3):311-23. PubMed ID: 224732
[TBL] [Abstract][Full Text] [Related]
22. Parathyroid hormone-related protein and interleukin-1 alpha synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo.
Sato K; Fujii Y; Kasono K; Ozawa M; Imamura H; Kanaji Y; Kurosawa H; Tsushima T; Shizume K
Endocrinology; 1989 May; 124(5):2172-8. PubMed ID: 2539970
[TBL] [Abstract][Full Text] [Related]
23. Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts.
Woo JT; Kasai S; Stern PH; Nagai K
J Bone Miner Res; 2000 Apr; 15(4):650-62. PubMed ID: 10780857
[TBL] [Abstract][Full Text] [Related]
24. Direct non-genomic effect of steroid hormones on superoxide anion generation in the bone resorbing osteoclasts.
Berger CE; Horrocks BR; Datta HK
Mol Cell Endocrinol; 1999 Mar; 149(1-2):53-9. PubMed ID: 10375017
[TBL] [Abstract][Full Text] [Related]
25. Ca2+ or phorbol ester but not inflammatory stimuli elevate inducible nitric oxide synthase messenger ribonucleic acid and nitric oxide (NO) release in avian osteoclasts: autocrine NO mediates Ca2+-inhibited bone resorption.
Sunyer T; Rothe L; Kirsch D; Jiang X; Anderson F; Osdoby P; Collin-Osdoby P
Endocrinology; 1997 May; 138(5):2148-62. PubMed ID: 9112415
[TBL] [Abstract][Full Text] [Related]
26. Tri-iodothyronine stimulates rat osteoclastic bone resorption by an indirect effect.
Allain TJ; Chambers TJ; Flanagan AM; McGregor AM
J Endocrinol; 1992 Jun; 133(3):327-31. PubMed ID: 1613434
[TBL] [Abstract][Full Text] [Related]
27. Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue.
Delaisse JM; Eeckhout Y; Vaes G
Endocrinology; 1988 Jul; 123(1):264-76. PubMed ID: 2838255
[TBL] [Abstract][Full Text] [Related]
28. Xanthine oxidase mediates cytokine-induced, but not hormone-induced bone resorption.
Kanczler JM; Millar TM; Bodamyali T; Blake DR; Stevens CR
Free Radic Res; 2003 Feb; 37(2):179-87. PubMed ID: 12653206
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.
de la Mata J; Uy HL; Guise TA; Story B; Boyce BF; Mundy GR; Roodman GD
J Clin Invest; 1995 Jun; 95(6):2846-52. PubMed ID: 7769125
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
[TBL] [Abstract][Full Text] [Related]
31. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis.
Löwik CW; van der Pluijm G; Bloys H; Hoekman K; Bijvoet OL; Aarden LA; Papapoulos SE
Biochem Biophys Res Commun; 1989 Aug; 162(3):1546-52. PubMed ID: 2548501
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts.
Yates AJ; Oreffo RO; Mayor K; Mundy GR
J Bone Miner Res; 1991 May; 6(5):473-8. PubMed ID: 2068953
[TBL] [Abstract][Full Text] [Related]
33. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts.
Hill PA; Murphy G; Docherty AJ; Hembry RM; Millican TA; Reynolds JJ; Meikle MC
J Cell Sci; 1994 Nov; 107 ( Pt 11)():3055-64. PubMed ID: 7699005
[TBL] [Abstract][Full Text] [Related]
34. Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity.
Kanatani M; Sugimoto T; Nishiyama K; Chihara K
J Bone Miner Res; 2000 May; 15(5):902-10. PubMed ID: 10804020
[TBL] [Abstract][Full Text] [Related]
35. Experimental study on the role of osteoclasts and free radicals in the mandibular invasion of VX2 carcinoma in Japanese white rabbits.
Fujimiya K; Sugihara K; Nishikawa T
Bone; 1997 Mar; 20(3):245-50. PubMed ID: 9071475
[TBL] [Abstract][Full Text] [Related]
36. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo.
Grey A; Mitnick MA; Masiukiewicz U; Sun BH; Rudikoff S; Jilka RL; Manolagas SC; Insogna K
Endocrinology; 1999 Oct; 140(10):4683-90. PubMed ID: 10499526
[TBL] [Abstract][Full Text] [Related]
37. Cystatin C, and inhibitor of bone resorption produced by osteoblasts.
Lerner UH; Johansson L; Ranjsö M; Rosenquist JB; Reinholt FP; Grubb A
Acta Physiol Scand; 1997 Sep; 161(1):81-92. PubMed ID: 9381954
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.
Thomson BM; Mundy GR; Chambers TJ
J Immunol; 1987 Feb; 138(3):775-9. PubMed ID: 3805716
[TBL] [Abstract][Full Text] [Related]
39. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.
Greenfield EM; Shaw SM; Gornik SA; Banks MA
J Clin Invest; 1995 Sep; 96(3):1238-44. PubMed ID: 7657797
[TBL] [Abstract][Full Text] [Related]
40. The effects of parathyroid hormone, colchicine, and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture.
Holtrop ME; Raisz LG; Simmons HA
J Cell Biol; 1974 Feb; 60(2):346-55. PubMed ID: 4855901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
